Star Imaging & Path Lab Ltd.
BBSE:STARIMAGIN74.70
INR
-2.30
(-2.99%)
Star Imaging & Path Lab Ltd.
BSE:STARIMAGIN
(Bombay Stock Exchange)
Recent
price
74.70
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.- Similar Companies
- Business
- Star Imaging & Path Lab Ltd. provides integrated diagnostic healthcare, medical imaging, and clinical pathology laboratory services in India. The company operates across two core business segments: Diagnostic Imaging (Radiology) and Clinical Laboratory Testing (Pathology). Its diagnostic radiology and medical imaging portfolio includes high-field magnetic resonance imaging (MRI); multi-slice computed tomography (CT) scans; digital radiography and routine X-rays; 3D and 4D ultrasound imaging; color Doppler studies; digital mammography; bone mineral densitometry (BMD/DEXA scans); positron emission tomography-computed tomography (PET-CT); electrocardiography (ECG); 2D echocardiography (ECHO); treadmill stress testing (TMT); pulmonary function testing (PFT); and electroencephalography (EEG). Its clinical pathology and laboratory services comprise clinical biochemistry; hematology and coagulation profiles; clinical pathology and urinalysis; microbiology and serology; histopathology and immunohistochemistry; cytopathology; immunology and endocrinology; infectious disease assays; molecular diagnostics; and specialized genetic screening tests. In addition, the company offers comprehensive preventive health check-up packages; chronic disease management profiles; prenatal and women health screening packages; oncology screening panels; corporate wellness and occupational health programs; pre-employment medical examinations; home sample collection services; mobile diagnostic vans; and digital tele-radiology reporting solutions catering to individual patients, corporate clients, medical practitioners, and healthcare institutions. In recent developments, Star Imaging & Path Lab Ltd. completed its public listing on the BSE SME platform (BSE: STARIMAGIN) to finance geographic network expansion, equipment modernization, and laboratory infrastructure upgrades. Over the past two years, the company has expanded its presence across the National Capital Region (Delhi-NCR) and northern India through the addition of new automated collection centers, hub-and-spoke processing facilities, and public-private partnership (PPP) diagnostic centers with regional government hospitals. The company has also integrated artificial intelligence-assisted imaging tools for accelerated radiological interpretation, broadened its molecular diagnostics and specialized pathology test menu, and established strategic diagnostic partnerships with institutional healthcare networks and corporate employers. Star Imaging & Path Lab Ltd. was founded in 1978 and is headquartered in New Delhi, India.